Bartolomeo Castellano, MD
Otolaryngology · Staten Island, NYNPI 1336122548
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Regeneron Healthcare Solutions, Inc. accounts for 68.0% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $157, 6.3 times the $25 reported in 2020. That places this record below the midpoint for otolaryngology clinicians in NY, where the typical reported total is $1,040.
Across 16 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$258
- Sanofi$61
- Inspire Medical Systems, Inc.$61
What the payments were for
- Food & beverage$380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $258 |
| Sanofi | 3 | $61 |
| Inspire Medical Systems, Inc. | 3 | $61 |
How this compares
$380 in reported general payments places this provider in the 30th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 450 | $4,331 |
| Fluocinolone Acetonide Oil | 106 | $3,194 |
| Azelastine Hcl | 126 | $2,224 |
| Ofloxacin | 33 | $1,703 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 23 | $1,132 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 49 | $329 |
| Doxycycline Hyclate | 32 | $294 |
| Prednisone | 78 | $145 |
| Azithromycin | 17 | $58 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Staten Island
- Homere Al MoutranStaten Island$11K
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Nora PerkinsAlbany$300K
- Moshe EphratNew Hyde Park$250K
- Gavin SetzenAlbany$243K
- Habibullah JamalRye Brook$179K
- Albert JenFlushing$171K
- Dennis KrausNew York$159K
- Nitin BhatiaWhite Plains$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.